亚盛医药在纳斯达克成功上市,募资约 1.26 亿美元1 月 24 日晚间,亚盛医药在美国纳斯达克成功挂牌上市,成为了 2025 年美股上市的首家生物医药公司。根据亚盛医药港股公告,该公司本次共计发行 732.5 万股,发行价为 17.25 美元,募资约 1.26 亿美元。亚盛医药成立于 2009 年,致力于研发肿瘤等领域的创新药,公司董事长、CEO 为杨大俊博士。此前,该公司已于 2019 年 ...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.